Heart Failure
A page on conditions in our medical research coverage, part of our health reporting, alongside the 5 reports filed on it so far.
Novo Nordisk ends two more phase 3 trials
Novo Nordisk has discontinued two late-stage heart failure trials for its drug ziltivekimab after a data review.
Novartis, Ionis heart drug fails in major Phase 3 trial
Novartis and Ionis Pharmaceuticals' experimental drug pelacarsen failed to reduce heart attacks, strokes or death in a Phase 3 study of over 8,000...
Heart Failure Drug Combo Effects Modeled
A pooled analysis of 38,753 patients from nine trials provides individualized estimates for how combinations of modern heart failure drugs affect...
Alnylam defends silencer drugs after AstraZeneca trial failure
Alnylam defends its RNAi drugs after AstraZeneca's heart disease trial failure, arguing they work even for patients on stabilizer therapies.
Transcatheter Tricuspid Repair Cuts Death
The TRIC-I-HF trial shows transcatheter tricuspid valve repair significantly reduces all-cause death and heart failure hospitalization in high-risk...